DSI announced today that it will be actively engaged in partnering meetings during the BIO International Convention. The 2022 BIO International Convention will transition to a virtual and in-person (optional) event format. This virtual gathering of the global biotech industry provides access to partners via BIO One-on-One Partnering and educational resources. Whether advocating CMC strategy, directing CMC operations or developing CMC submission content that represent the best interests of emerging biotech, DSI is focused on the critical CMC issues and build programs that enhance development.
With technological innovation rising and the cost of technology dropping, we now have the ability to connect almost anytime and anywhere. The COVID-19 pandemic has created a world more dependent on digital tools, and has ultimately created a more digitally transformed pharma industry. Even with the significant hurdles that need to be overcome, DSI who has operated virtually for the last fourteen years continues to serve its customers and partners virtually and in person within the highly regulated pharmaceutical industry.
About DSI
DSI is a full-service regulatory drug development consulting firm for pharmaceuticals, biologics and new drug and delivery platforms. DSI provides regulatory, technical, and project management consulting services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and next generation therapy products.
Since 2007 we have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence.
Whether advocating CMC strategy, directing CMC operations or developing CMC submission content that represent the best interests of emerging biotech, we focus on the critical CMC issues and build programs that enhance development.
Connect with DSI on LinkedIn or visit www.dsinpharmatics.com for more information.
CONTACT:
Meranda Parascandola
Head of Business Development and Marketing
Mparascandola@dsinpharmatics.com
Design Space InPharmatics, llc. (DSI)
Tel: (855) 805-8402×104
